N-803 + Durvalumab

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint InhibitorsNCT03228667IBRXPhase 2Active not recruiting2029-08-31Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.